Status:

WITHDRAWN

Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)

Lead Sponsor:

Valo Health, Inc.

Conditions:

Myocardial Infarction

Eligibility:

All Genders

18-90 years

Phase:

PHASE2

Brief Summary

Study OPL-0301-201 is intended to generate efficacy and safety data of OPL-0301 in participants with post-myocardial infarction (MI) left ventricular dysfunction (LVD)

Detailed Description

OPL-0301 is intended to address the disease state of post-myocardial infarction (MI) left ventricular dysfunction (LVD). MI is a manifestation of atherosclerotic coronary artery disease, the pathogene...

Eligibility Criteria

Inclusion

  • Are male or female between 18 and 90 years of age, inclusive, at the time of signing the informed consent
  • Are hospitalized with acute ST-Elevated Myocardial Infarction (STEMI), defined based on American Heart Association (AHA)/American College of Cardiology (ACC) criteria
  • Have cardiac troponin-I (cTnI), cardiac troponin-T (cTnT) levels ≥10x upper limit of normal (ULN) at least once during the index event of myocardial infarction

Exclusion

  • Previous history of documented myocardial infarction
  • Previous history of percutaneous coronary intervention (PCI) within 6 months or coronary artery bypass graft surgery (CABG) or valvular heart surgery at any time prior to screening
  • Previous history of documented chronic left ventricular dysfunction with ejection fraction (EF) \< 50%
  • Previous history of decompensated heart failure
  • Previous history of documented specific cardiomyopathy (including but not limited to hypertrophic cardiomyopathy (HCM), amyloid, sarcoid, etc.)
  • Previous history of documented arrhythmias
  • Are being treated with Sphingosine-1 Phosphate (S1P) modulators (fingolimod, siponimod, ozanimod, ponesimod)

Key Trial Info

Start Date :

September 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2024

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05327855

Start Date

September 1 2022

End Date

November 1 2024

Last Update

February 21 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.